TipRanks
Community Health (DE:CG5)
FRANKFURT:CG5
Germany Market

Community Health (CG5) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

CG5 Analyst Ratings

Hold
8Ratings
Hold
2 Buy
4 Hold
2 Sell
Based on 8 analysts giving stock ratings to
Community
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CG5 Stock 12 Month Forecast

Average Price Target

€2.89
▲(16.53% Upside)
Based on 8 Wall Street analysts offering 12 month price targets for Community Health in the last 3 months. The average price target is €2.89 with a high forecast of €3.51 and a low forecast of €2.19. The average price target represents a 16.53% change from the last price of €2.48.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"€1","4":"€4","1.75":"€1.75","2.5":"€2.5","3.25":"€3.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3.51181244,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€3.51</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.8899289870833336,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€2.89</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.194882775,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€2.19</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,1.75,2.5,3.25,4],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.5,2.577831726153846,2.6556634523076923,2.7334951784615384,2.8113269046153846,2.8891586307692307,2.966990356923077,3.044822083076923,3.122653809230769,3.2004855353846153,3.2783172615384615,3.3561489876923076,3.4339807138461538,{"y":3.51181244,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.5,2.5299945374679487,2.5599890749358973,2.589983612403846,2.619978149871795,2.649972687339744,2.6799672248076924,2.709961762275641,2.73995629974359,2.7699508372115385,2.7999453746794876,2.8299399121474362,2.859934449615385,{"y":2.8899289870833336,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.5,2.4765294442307693,2.4530588884615385,2.429588332692308,2.406117776923077,2.3826472211538463,2.3591766653846156,2.3357061096153844,2.3122355538461536,2.288764998076923,2.265294442307692,2.2418238865384614,2.2183533307692307,{"y":2.194882775,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.32,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.639,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.3,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.08,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.7,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":2.7,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.86,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.56,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.4,"date":1777593600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":2.36,"date":1780272000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.1,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.4,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.5,"date":1788220800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€3.51Average Price Target€2.89Lowest Price Target€2.19
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Raymond James Analyst forecast on DE:CG5
Raymond James
Raymond James
―
Sell
―
Reiterated
09/28/26
Analysts Offer Insights on Healthcare Companies: Community Health (NYSE: CYH) and Cronos Group (NASDAQ: CRON)
BMO Capital Analyst forecast on DE:CG5
BMO Capital
BMO Capital
€2.63
Hold
6.20%
Upside
Initiated
09/23/26
Community Health initiated with a Market Perform at BMO CapitalCommunity Health initiated with a Market Perform at BMO Capital
Truist Financial Analyst forecast on DE:CG5
Truist Financial
Truist Financial
€3.29→€2.85
Hold
15.05%
Upside
Reiterated
07/27/26
Community Health (CYH) Gets a Hold from Truist Financial
RBC Capital Analyst forecast on DE:CG5
RBC Capital
RBC Capital
€4.39→€3.51
Buy
41.61%
Upside
Reiterated
07/26/26
Community Health (CYH) Gets a Buy from RBC Capital
Oppenheimer
€3.51
Buy
41.61%
Upside
Reiterated
07/24/26
Analysts Offer Insights on Healthcare Companies: Atricure (NASDAQ: ATRC), Prime Medicine, Inc. (NASDAQ: PRME) and Community Health (NYSE: CYH)
UBS
€2.81→€2.63
Hold
6.20%
Upside
Reiterated
07/24/26
Community Health price target lowered to $3 from $3.20 at UBSCommunity Health price target lowered to $3 from $3.20 at UBS
Guggenheim Analyst forecast on DE:CG5
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
―
Hold
―
Reiterated
07/23/26
Guggenheim Reaffirms Their Hold Rating on Community Health (CYH)
Barclays
€2.63→€2.19
Sell
-11.50%
Downside
Reiterated
07/23/26
Analysts Offer Insights on Healthcare Companies: Community Health (NYSE: CYH), AnaptysBio (NASDAQ: ANAB) and Repligen (NASDAQ: RGEN)
Wells Fargo Analyst forecast on DE:CG5
Wells Fargo
Wells Fargo
€1.76
Sell
-29.20%
Downside
Assigned
04/27/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Medtronic (NYSE: MDT), Neogen (NASDAQ: NEOG) and Community Health (NYSE: CYH)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Raymond James Analyst forecast on DE:CG5
Raymond James
Raymond James
―
Sell
―
Reiterated
09/28/26
Analysts Offer Insights on Healthcare Companies: Community Health (NYSE: CYH) and Cronos Group (NASDAQ: CRON)
BMO Capital Analyst forecast on DE:CG5
BMO Capital
BMO Capital
€2.63
Hold
6.20%
Upside
Initiated
09/23/26
Community Health initiated with a Market Perform at BMO CapitalCommunity Health initiated with a Market Perform at BMO Capital
Truist Financial Analyst forecast on DE:CG5
Truist Financial
Truist Financial
€3.29→€2.85
Hold
15.05%
Upside
Reiterated
07/27/26
Community Health (CYH) Gets a Hold from Truist Financial
RBC Capital Analyst forecast on DE:CG5
RBC Capital
RBC Capital
€4.39→€3.51
Buy
41.61%
Upside
Reiterated
07/26/26
Community Health (CYH) Gets a Buy from RBC Capital
Oppenheimer
€3.51
Buy
41.61%
Upside
Reiterated
07/24/26
Analysts Offer Insights on Healthcare Companies: Atricure (NASDAQ: ATRC), Prime Medicine, Inc. (NASDAQ: PRME) and Community Health (NYSE: CYH)
UBS
€2.81→€2.63
Hold
6.20%
Upside
Reiterated
07/24/26
Community Health price target lowered to $3 from $3.20 at UBSCommunity Health price target lowered to $3 from $3.20 at UBS
Guggenheim Analyst forecast on DE:CG5
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
―
Hold
―
Reiterated
07/23/26
Guggenheim Reaffirms Their Hold Rating on Community Health (CYH)
Barclays
€2.63→€2.19
Sell
-11.50%
Downside
Reiterated
07/23/26
Analysts Offer Insights on Healthcare Companies: Community Health (NYSE: CYH), AnaptysBio (NASDAQ: ANAB) and Repligen (NASDAQ: RGEN)
Wells Fargo Analyst forecast on DE:CG5
Wells Fargo
Wells Fargo
€1.76
Sell
-29.20%
Downside
Assigned
04/27/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Medtronic (NYSE: MDT), Neogen (NASDAQ: NEOG) and Community Health (NYSE: CYH)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ESTAEstablishment Labs Holdings
LGNDLigand Pharma
HROWHarrow Health
STOKStoke Therapeutics
AXGNAxoGen
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Community Health

3 Months
Success Rate
20/40 ratings generated profit
50%
Average Return
+4.88%
Copying Michael Wiederhorn's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +4.88% per trade.
1 Year
Success Rate
19/40 ratings generated profit
48%
Average Return
+15.09%
Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 47.50% of your transactions generating a profit, with an average return of +15.09% per trade.
2 Years
Success Rate
17/40 ratings generated profit
43%
Average Return
+9.74%
Copying Michael Wiederhorn's trades and holding each position for 2 Years would result in 42.50% of your transactions generating a profit, with an average return of +9.74% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CG5 Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
2
2
0
0
0
Buy
1
0
3
3
3
Hold
4
4
5
5
6
Sell
3
2
2
2
3
Strong Sell
0
0
0
0
0
total
10
8
10
10
12
In the current month, CG5 has received 3 Buy Ratings, 6 Hold Ratings, and 3 Sell Ratings. CG5 average Analyst price target in the past 3 months is 2.89.
Each month's total comprises the sum of three months' worth of ratings.

CG5 Financial Forecast

CG5 Earnings Forecast

Next quarter’s earnings estimate for CG5 is -€0.26 with a range of -€0.34 to -€0.12. The previous quarter’s EPS was -€0.17. CG5 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CG5 has Performed in-line its overall industry.
Next quarter’s earnings estimate for CG5 is -€0.26 with a range of -€0.34 to -€0.12. The previous quarter’s EPS was -€0.17. CG5 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CG5 has Performed in-line its overall industry.

CG5 Sales Forecast

Next quarter’s sales forecast for CG5 is €2.45B with a range of €2.41B to €2.47B. The previous quarter’s sales results were €2.47B. CG5 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CG5 has Performed in-line its overall industry.
Next quarter’s sales forecast for CG5 is €2.45B with a range of €2.41B to €2.47B. The previous quarter’s sales results were €2.47B. CG5 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CG5 has Performed in-line its overall industry.

CG5 Stock Forecast FAQ

What is DE:CG5’s average 12-month price target, according to analysts?
Based on analyst ratings, Community Health’s 12-month average price target is 2.89.
    What is DE:CG5’s upside potential, based on the analysts’ average price target?
    Community Health has 16.53% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Community Health a Buy, Sell or Hold?
          Community Health has a consensus rating of Hold, which is based on 2 buy ratings, 4 hold ratings and 2 sell ratings.
            What is Community Health’s share price target?
            The average share price target for Community Health is 2.89. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €3.51 ,and the lowest forecast is €2.19. The average share price target represents 16.53% Increase from the current price of €2.48.
              What do analysts say about Community Health?
              Community Health’s analyst rating consensus is a Hold. This is based on the ratings of 8 Wall Streets Analysts.
                How can I buy shares of Community Health?
                To buy shares of DE:CG5, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.